FDA Inspection 1242486 — Ningbo Renjian Pharmaceutical Group Co., Ltd

Ningbo Renjian Pharmaceutical Group Co., Ltd — FEI 3004160744

The FDA completed an inspection of Ningbo Renjian Pharmaceutical Group Co., Ltd on May 17, 2024 in Ningbo. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Veterinary.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
May 17, 2024
Fiscal Year
2024
Product Type
Veterinary
Project Area
Pre-Approval Eval. of Animal Drugs and Food Additives
Location
Ningbo (China)